Effectiveness of Different Rituximab Doses Combined with Leflunomide in the Treatment or Retreatment of Rheumatoid Arthritis: Part 2 of a Randomized, Placebo-Controlled, Investigator-Initiated Clinical Trial (AMARA)

Background: The optimal dose of rituximab in combination with leflunomide in patients with rheumatoid arthritis (RA) is not known. Methods: In Part 1 (previously reported) of the investigator-initiated AMARA study (EudraCT 2009-015950-39; ClinicalTrials.gov NCT01244958), improvements at week (W)24 w...

Descripción completa

Detalles Bibliográficos
Autores principales: Koehm, Michaela, Foldenauer, Ann C., Rossmanith, Tanja, Alten, Rieke, Aringer, Martin, Backhaus, Marina, Burmester, Gerd R., Feist, Eugen, Kellner, Herbert, Krueger, Klaus, Müller-Ladner, Ulf, Rubbert-Roth, Andrea, Tony, Hans-Peter, Wassenberg, Siegfried, Burkhardt, Harald, Behrens, Frank
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9784147/
https://www.ncbi.nlm.nih.gov/pubmed/36555933
http://dx.doi.org/10.3390/jcm11247316

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9784147/
https://www.ncbi.nlm.nih.gov/pubmed/36555933
http://dx.doi.org/10.3390/jcm11247316

Ejemplares similares